I welcome everyone!
W. The price updated liquidity from below last week and reached an imbalance.
As part of the ascending structure, I am considering a continuation of the decline to the levels in the discount zone ($28 297 -$24 800)
D. On the daily TF, there was a breakdown of the structure to a downward one with the price stopping in the imbalance zone. Within the descending wave, there are resistance zones, from which I consider sales with targets on the weekly TF.
Happy trading!
❗️Not a financial recommendation, before entering into a particular transaction, conduct an analysis of the asset yourself.
W. The price updated liquidity from below last week and reached an imbalance.
As part of the ascending structure, I am considering a continuation of the decline to the levels in the discount zone ($28 297 -$24 800)
D. On the daily TF, there was a breakdown of the structure to a downward one with the price stopping in the imbalance zone. Within the descending wave, there are resistance zones, from which I consider sales with targets on the weekly TF.
Happy trading!
❗️Not a financial recommendation, before entering into a particular transaction, conduct an analysis of the asset yourself.
Note
After the test of the daily OB, the price updated the low of $28 861, completely covering the imb DI also expect a continued decline into the DM zone
Мой Телеграмм канал: t.me/mari_trade
Сообщество в ВК: vk.com/mari__trade
X: Mari_trading
Сообщество в ВК: vk.com/mari__trade
X: Mari_trading
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Мой Телеграмм канал: t.me/mari_trade
Сообщество в ВК: vk.com/mari__trade
X: Mari_trading
Сообщество в ВК: vk.com/mari__trade
X: Mari_trading
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.